Literature DB >> 30582451

Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.

Kazuya Miyagawa1,2,3, Minyi Shi4,2, Pin-I Chen1,2,3, Jan K Hennigs1,2,3, Zhixin Zhao4,2, Mouer Wang5,2, Caiyun G Li1,2,3, Toshie Saito1,2,3, Shalina Taylor1,2,3, Silin Sa1,2,3, Aiqin Cao1,2,3, Lingli Wang1,2,3, Michael P Snyder4,2, Marlene Rabinovitch1,2,3.   

Abstract

RATIONALE: Maintaining endothelial cells (EC) as a monolayer in the vessel wall depends on their metabolic state and gene expression profile, features influenced by contact with neighboring cells such as pericytes and smooth muscle cells (SMC). Failure to regenerate a normal EC monolayer in response to injury can result in occlusive neointima formation in diseases such as atherosclerosis and pulmonary arterial hypertension.
OBJECTIVE: We investigated the nature and functional importance of contact-dependent communication between SMC and EC to maintain EC integrity. METHODS AND
RESULTS: We found that in SMC and EC contact cocultures, BMPR2 (bone morphogenetic protein receptor 2) is required by both cell types to produce collagen IV to activate ILK (integrin-linked kinase). This enzyme directs p-JNK (phospho-c-Jun N-terminal kinase) to the EC membrane, where it stabilizes presenilin1 and releases N1ICD (Notch1 intracellular domain) to promote EC proliferation. This response is necessary for EC regeneration after carotid artery injury. It is deficient in EC-SMC Bmpr2 double heterozygous mice in association with reduced collagen IV production, decreased N1ICD, and attenuated EC proliferation, but can be rescued by targeting N1ICD to EC. Deletion of EC- Notch1 in transgenic mice worsens hypoxia-induced pulmonary hypertension, in association with impaired EC regenerative function associated with loss of precapillary arteries. We further determined that N1ICD maintains EC proliferative capacity by increasing mitochondrial mass and by inducing the phosphofructokinase PFKFB3 (fructose-2,6-bisphosphatase 3). Chromatin immunoprecipitation sequencing analyses showed that PFKFB3 is required for citrate-dependent H3K27 acetylation at enhancer sites of genes regulated by the acetyl transferase p300 and by N1ICD or the N1ICD target MYC and necessary for EC proliferation and homeostasis.
CONCLUSIONS: Thus, SMC-EC contact is required for activation of Notch1 by BMPR2, to coordinate metabolism with chromatin remodeling of genes that enable EC regeneration, and to maintain monolayer integrity and vascular homeostasis in response to injury.

Entities:  

Keywords:  cell communication; endothelial cells; epigenomics; metabolism; pulmonary hypertension; regeneration; vascular remodeling

Mesh:

Substances:

Year:  2019        PMID: 30582451      PMCID: PMC6400637          DOI: 10.1161/CIRCRESAHA.118.313374

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

Review 1.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

2.  Dynamic binding of RBPJ is determined by Notch signaling status.

Authors:  David Castel; Philippos Mourikis; Stefanie J J Bartels; Arie B Brinkman; Shahragim Tajbakhsh; Hendrik G Stunnenberg
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

3.  Different modes of endothelial-smooth muscle cell interaction elicit differential β-catenin phosphorylations and endothelial functions.

Authors:  Shun-Fu Chang; Li-Jing Chen; Pei-Ling Lee; Ding-Yu Lee; Shu Chien; Jeng-Jiann Chiu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

Review 4.  Robustness in angiogenesis: notch and BMP shaping waves.

Authors:  Karen Beets; Danny Huylebroeck; Iván M Moya; Lieve Umans; An Zwijsen
Journal:  Trends Genet       Date:  2012-12-30       Impact factor: 11.639

5.  Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.

Authors:  Tero-Pekka Alastalo; Molong Li; Vinicio de Jesus Perez; David Pham; Hirofumi Sawada; Jordon K Wang; Minna Koskenvuo; Lingli Wang; Bruce A Freeman; Howard Y Chang; Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

6.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Yuanyuan Wei; Kiril Bidzhekov; Felix Gremse; Jochen Grommes; Remco T A Megens; Kathrin Heyll; Heidi Noels; Michael Hristov; Shusheng Wang; Fabian Kiessling; Eric N Olson; Christian Weber
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

Review 7.  Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.

Authors:  Kazuyuki Yahagi; Frank D Kolodgie; Fumiyuki Otsuka; Aloke V Finn; Harry R Davis; Michael Joner; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2015-10-27       Impact factor: 32.419

8.  Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.

Authors:  Elaine Soon; Alexi Crosby; Mark Southwood; Peiran Yang; Tamara Tajsic; Mark Toshner; Sarah Appleby; Catherine M Shanahan; Kenneth D Bloch; Joanna Pepke-Zaba; Paul Upton; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 30.528

9.  Notch3 signaling promotes the development of pulmonary arterial hypertension.

Authors:  Xiaodong Li; Xiaoxue Zhang; Robin Leathers; Ayako Makino; Chengqun Huang; Pouria Parsa; Jesus Macias; Jason X-J Yuan; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

10.  A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors.

Authors:  Elena Gabriela Chiorean; Patricia LoRusso; Robert Matthew Strother; Jennifer R Diamond; Anne Younger; Wells A Messersmith; Lieve Adriaens; Liming Liu; Richard J Kao; Albert Thomas DiCioccio; Ana Kostic; Russell Leek; Adrian Harris; Antonio Jimeno
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

View more
  27 in total

1.  Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Authors:  Elena A Goncharova; Stephen Y Chan; Corey E Ventetuolo; Norbert Weissmann; Ralph T Schermuly; Christopher J Mullin; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

2.  Endothelial Notch1 in Pulmonary Hypertension.

Authors:  Aleksandra Babicheva; Jason X-J Yuan
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

3.  Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9.

Authors:  Qi Jia; Zhiqiang Hu; Nannan Song; Weike Mao
Journal:  Cardiovasc Drugs Ther       Date:  2022-01-28       Impact factor: 3.727

4.  Finding and Verifying Enhancers for Endothelial-Expressed Genes.

Authors:  Alice Neal; Helena Rodriguez-Caro; Sarah De Val
Journal:  Methods Mol Biol       Date:  2022

5.  Single-Cell RNA Sequencing Reveals Novel Genes Regulated by Hypoxia in the Lung Vasculature.

Authors:  Shelby Thomas; Sathiyanarayanan Manivannan; Vidu Garg; Brenda Lilly
Journal:  J Vasc Res       Date:  2022-03-16       Impact factor: 2.045

6.  iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.

Authors:  Mingxia Gu; Michele Donato; Minzhe Guo; Neil Wary; Yifei Miao; Shuai Mao; Toshie Saito; Shoichiro Otsuki; Lingli Wang; Rebecca L Harper; Silin Sa; Purvesh Khatri; Marlene Rabinovitch
Journal:  Sci Transl Med       Date:  2021-05-05       Impact factor: 17.956

7.  PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.

Authors:  Jan K Hennigs; Aiqin Cao; Caiyun G Li; Minyi Shi; Julia Mienert; Kazuya Miyagawa; Jakob Körbelin; David P Marciano; Pin-I Chen; Matthew Roughley; Matthew V Elliott; Rebecca L Harper; Matthew A Bill; James Chappell; Jan-Renier Moonen; Isabel Diebold; Lingli Wang; Michael P Snyder; Marlene Rabinovitch
Journal:  Circ Res       Date:  2020-12-16       Impact factor: 17.367

Review 8.  Endothelial cells in the pathogenesis of pulmonary arterial hypertension.

Authors:  Colin E Evans; Nicholas D Cober; Zhiyu Dai; Duncan J Stewart; You-Yang Zhao
Journal:  Eur Respir J       Date:  2021-09-02       Impact factor: 33.795

9.  ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension.

Authors:  Dan Li; Ning-Yi Shao; Jan-Renier Moonen; Zhixin Zhao; Minyi Shi; Shoichiro Otsuki; Lingli Wang; Tiffany Nguyen; Elaine Yan; David P Marciano; Kévin Contrepois; Caiyun G Li; Joseph C Wu; Michael P Snyder; Marlene Rabinovitch
Journal:  Circulation       Date:  2021-03-25       Impact factor: 39.918

10.  Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease.

Authors:  Sadhan Das; Marpadga A Reddy; Rama Natarajan
Journal:  Curr Opin Cardiol       Date:  2020-05       Impact factor: 2.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.